Language Select
Varian Logo

Press Releases

March 14, 2018
Varian (NYSE: VAR) today announced it has received clearances from the U.S. antitrust authorities and the German Federal Cartel Office (FCO) on the proposed acquisition of all of the outstanding... Read more
March 12, 2018
Varian (NYSE: VAR) today announced that it will report results for the second quarter of fiscal year 2018 after market close on Wednesday, April 25, 2018. The news release will be followed by a... Read more
March 09, 2018
Varian (NYSE: VAR) has been selected by the Instituto Mexicano del Seguro Social (IMSS) to equip seven treatment centers across Mexico with modern radiotherapy treatment systems, including the... Read more
March 05, 2018
Varian (NYSE: VAR) and the University of Maryland School of Medicine (UMSOM) announced today they have reached their first educational milestone at the Maryland Proton Treatment Center (MPTC):... Read more
March 01, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Barclays Global Healthcare... Read more
February 26, 2018
Varian (NYSE: VAR) today announced it will be demonstrating its portfolio of software solutions for smarter cancer care, March 5-8 in Las Vegas, NV at HIMSS18, booth 10518. Varian provides a... Read more
February 22, 2018
Varian (NYSE: VAR) today announced its ARIA® oncology information system has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT... Read more
February 22, 2018
Varian (NYSE: VAR) today announced it has acquired privately-held Montreal-based Evinance Innovation, Inc., a clinical decision support (CDS) software company. This acquisition expands the... Read more
February 20, 2018
Varian (NYSE: VAR) today announced three of its cancer care solutions have been named Category Leaders in the 2018 Best in KLAS: Software and Services Report by KLAS, an independent research firm... Read more
February 06, 2018
Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]